Northern Trust Corp Cidara Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$0.64 - $0.92 $139 - $200
-218 Reduced 0.14%
160,356 $147,000
Q4 2023

Feb 13, 2024
BUY
$0.68 - $0.97 $22,174 - $31,630
32,609 Added 25.48%
160,574 $126,000
Q2 2023

Aug 11, 2023
BUY
$1.01 - $1.42 $16,184 - $22,754
16,024 Added 14.31%
127,965 $144,000
Q1 2023

May 15, 2023
BUY
$0.75 - $1.98 $4,838 - $12,772
6,451 Added 6.12%
111,941 $142,000
Q3 2022

Nov 14, 2022
BUY
$0.45 - $13.0 $3,193 - $92,261
7,097 Added 7.21%
105,490 $66,000
Q1 2022

May 13, 2022
SELL
$0.67 - $1.39 $8,109 - $16,824
-12,104 Reduced 10.95%
98,393 $82,000
Q4 2021

Feb 08, 2022
BUY
$1.18 - $2.18 $48,114 - $88,889
40,775 Added 58.48%
110,497 $140,000
Q3 2021

Nov 15, 2021
SELL
$1.48 - $2.35 $4,004 - $6,359
-2,706 Reduced 3.74%
69,722 $156,000
Q2 2021

Aug 13, 2021
SELL
$1.87 - $2.7 $564,698 - $815,340
-301,978 Reduced 80.66%
72,428 $146,000
Q1 2021

May 12, 2021
SELL
$2.06 - $3.01 $32,160 - $46,992
-15,612 Reduced 4.0%
374,406 $996,000
Q4 2020

Feb 11, 2021
BUY
$1.99 - $3.25 $10,111 - $16,513
5,081 Added 1.32%
390,018 $780,000
Q3 2020

Nov 16, 2020
BUY
$2.85 - $4.1 $760,730 - $1.09 Million
266,923 Added 226.18%
384,937 $1.1 Million
Q2 2020

Aug 14, 2020
BUY
$2.39 - $4.0 $166,322 - $278,364
69,591 Added 143.71%
118,014 $436,000
Q1 2020

May 14, 2020
BUY
$1.74 - $4.26 $33,385 - $81,736
19,187 Added 65.63%
48,423 $120,000
Q4 2019

Feb 14, 2020
BUY
$1.77 - $3.84 $7,308 - $15,855
4,129 Added 16.45%
29,236 $112,000
Q3 2019

Nov 13, 2019
SELL
$1.25 - $2.35 $1,177 - $2,213
-942 Reduced 3.62%
25,107 $50,000
Q2 2019

Aug 13, 2019
SELL
$1.49 - $2.94 $5,326 - $10,510
-3,575 Reduced 12.07%
26,049 $44,000
Q1 2019

May 13, 2019
SELL
$2.35 - $3.27 $32,326 - $44,982
-13,756 Reduced 31.71%
29,624 $79,000
Q4 2018

Feb 12, 2019
BUY
$2.1 - $4.5 $543 - $1,165
259 Added 0.6%
43,380 $102,000
Q3 2018

Nov 14, 2018
BUY
$3.7 - $5.25 $21,219 - $30,108
5,735 Added 15.34%
43,121 $190,000
Q2 2018

Aug 14, 2018
BUY
$3.75 - $6.05 $6,768 - $10,920
1,805 Added 5.07%
37,386 $195,000
Q1 2018

May 09, 2018
BUY
$4.0 - $8.15 $72,056 - $146,814
18,014 Added 102.54%
35,581 $142,000
Q4 2017

Feb 14, 2018
SELL
$6.35 - $8.75 $3,638 - $5,013
-573 Reduced 3.16%
17,567 $119,000
Q3 2017

Nov 13, 2017
BUY
$5.75 - $8.1 $104,305 - $146,934
18,140
18,140 $147,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email